CA2348374C - Method for producing 4- [(2',5'- diamino-6'- halopyrimidine- 4'-yl)amino]- cyclopent- 2-enylmethanols - Google Patents

Method for producing 4- [(2',5'- diamino-6'- halopyrimidine- 4'-yl)amino]- cyclopent- 2-enylmethanols Download PDF

Info

Publication number
CA2348374C
CA2348374C CA002348374A CA2348374A CA2348374C CA 2348374 C CA2348374 C CA 2348374C CA 002348374 A CA002348374 A CA 002348374A CA 2348374 A CA2348374 A CA 2348374A CA 2348374 C CA2348374 C CA 2348374C
Authority
CA
Canada
Prior art keywords
diamino
amino
cyclopent
enylmethanols
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002348374A
Other languages
French (fr)
Other versions
CA2348374A1 (en
Inventor
Walter Brieden
Elie Saikali
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lonza AG
Original Assignee
Lonza AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lonza AG filed Critical Lonza AG
Publication of CA2348374A1 publication Critical patent/CA2348374A1/en
Application granted granted Critical
Publication of CA2348374C publication Critical patent/CA2348374C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50Three nitrogen atoms

Abstract

A novel process for preparing 4-[(2',5'-diamino-6'--halopyrimidin-4'-yl)amino]cyclopent-2-enylmethanols of the general formula (see formula I) in which X is a halogen atom, is described. According to this process, a 2,5-diamino-4,6-dihalopyrimidine of the general formula (see formula II) in which X is as defined above, is reacted with a 4-aminocyclopent-2-enylmethanol of the formula (see formula III) or one of its salts, in the presence of a base in a polar protic solvent.

Description

Method for producing 4-[(2',5'-Diamino-61-halopyrimidin-4'-yl)amino] cyclopent-2-enylmethanols Description The present invention relates to a novel process for preparing 4-[(2',5'-diamino-61-halopyrimidin-4'-yl)amino]cyclopent-2-enylmethanols of the general formula X
H,N N
HO ~ . I
HI~ NIi2 4-[(2',5'-diamino-6'-halopyrimidin-4'-yl)-amino]cyclopent-2-enylmethanols are important intermediates for preparing antiviral nucleotide derivatives (WO 91/01310).

The 3-step synthesis of 4-[(2',5'-diamino-6'-chloropyrimidin-4'-yl)amino]cyclopent-2-enylmethanol starting from 4-acetamidocyclopent-2-enylmethanol by reaction with 2-amino-4,6dichloropyrimidine in butanol using diisopropylethylamine as base is known. Here, the [(21-amino-6'-chloropyrimidin-4'-yl)amino]cyclopent-2-enylmethanol is initially formed, which is then converted in a subsequent step by diazotization into the corresponding amine which is then hydrolysed to give the end product (J. Chem. Soc. Perkins Trans, 1, 1992).

This process has the disadvantage that it is too costly and that the desired end product is obtained in only moderate yield.

It is the object of the present invention to provide a 1-step and thus more cost-efficient process for preparing 4-[(2',5'-diamino-6'-halopyrimidin-4'-yl)amino]cyclopent-2-enylmethanols in which the desired products are obtained in good yield.
According to the invention, there is provided a process for preparing 4-[(2',5'-diamino-6'-halopyrimidin-4'-yl)amino]cyclopent-2-enylmethanols of the general formula x H2 O'l HO H~,=~N/~NH2 in which X is a halogen atom, wherein a 2,5-diamino-4,6-dihalopyrimidine of the general formula x H2N / N lI

in which X is defined as above, is reacted with a 4-aminocyclopent-2-enylmethanol of the formula ~-I U NHl I I I
or one of its salts, in the presence of a base selected from the group consisting of an alkali metal bicarbonate, an alkali earth metal bicarbonate, an alkali metal carbonate and an alkali earth metal carbonate, in a polar protic solvent to give the end product of the general formula I.
Surprisingly, it has been found that, if instead of 2-amino-4,6-dichloropyri.midine, a 2,5-diamino-4,6-dihalopyrimidine of the general formula x NzN ~
~ N II
X N NHI

is used as starting material, and this is allowed to react in the presence of a base in a polar protic solvent with a 4-aminocyclopent-2-enylmethanol of the formula HO NH2 z1t or one of its salts, the desired eiid product of the general formula x F{0 ~u i ~t N Nl~

is obtained much more cost-efficiently and in good yield.

The substituent X is a halogen atom, such as F, Cl, Br or I.

The 2,5-diamino-4,6-dihalopyrimdines, such as the 2,5-diamino-4,6-dichloropyrimidine, can be prepared in accordance with EP-A 0 684 326.

The 4-aminocyclopent-2-enylmethanols used can be both the racemic and the optically active compounds, such as (1R,4S)-, (1S,4R)-, (lR,4R)-, or (iS,4S)-4-aminocyclopent-2-enylmethanols.
Suitable salts thereof are the acid addition salts, in particular the hydrobalide salts, for example the hydrochlorides or hydrobromides. These 4-aminocyclopent-2-enylmethanols, in particular the (1R,4S)- or the (1S,4R)-enantiomers, can be prepared in accordance with WO 97/45529.

The reaction is advantageously carried out in the presence of an alkali metal carbonate or alkaline earth metal carbonate, alkali metal bicarbonate or alkaline earth metal bicarbonate or in the presence of nitrogen bases, such as, for example, tert. amines, as base. The alkali metal carbonate or alkali metal bicarbonate used can be sodium carbonate, potassium carbonate or sodium bicarbonate or potassium bicarbonate. The alkaline earth metal carbonate or alkaline earth metal bicarbonate used can be calcium carbonate or magnesium carbonate or calcium bicarbonate.

Suitable tert. amines are, for example, triethylamine and diisopropylethylamine. The reaction is preferably carried out in the presence of an alkali metal bicarbonate such as sodium bicarbonate or in the presence of a tert. amine such as diisopropylethylamine.

The base is advantageously employed in excess, based on the 2,5-diamino-4,6-dihalopyrimidine; preferably, 1 to 4 mol of base are employed per mole of 2,5-diamino-4,6-dihalopyrimidine.

Suitable polar protic solvents are, in particular, C1_4-alcohols, such as methanol, ethanol, propanol and its isomers, and butanol and its isomers.

The reaction is advantageously carried out at a temperature of from 20 C to the reflux temperature of the solvent in question, preferably from 50 C to the reflux temperature.

Advantageously, the 4-aminocyclopent-2-enylmethanol and the 2,5-diamino-4,6-dihalopyrimidine are employed in equimolar amounts.

After a customary reaction time of from 2 to 20 h, the end products of formula I, preferably the (1S,4R)-4-[(2',-5'-diamino-6'-halopyrimidin-4'-yl)-amino]cyclopent-2-enylmethanol, can then be obtained by customary work-up methods.
Examples Example 1 Preparation of 4-[(21,51 -diamino-61 -chloropyrimidin-4'-yl)amino]cyclopent-2--enylmethanol in the presence of sodium bicarbonate.

(1S,4R) -4-aminocyclopent-2-enylmethanol hydrochloride (0.14 mol, 23.25 g) , ethanol (3 mol, 138.12 g, 176 m:l), 2,5-diamino-4,6-dichloropyri.midine (0.14 mol, 25 g) and. sodium bicarbonate (0.34 mol, 28.68 g) were added to a dry reactor. This mixture was heated at reflux temperature (about 80 C) for 16 h.
The rate of conversion was tested by TLC using 13/i methylene chloride:methanol as mobile phase. The reaction mixture was cooled to room temperature and stirred for 45 min. The salts were removed by filtration and the filter cake was washed twice with ethanol (0.86 mol, 39.5 g, 50 ml).

2/3 of the organic phase were removed by distillation under reduced pressure, and hexane (150 ml) was then added dropwise. The suspension was cooled to below 10 C. After filtration, the product was dried under reduced pressure at 50 C.
This gave 21.5 g (0.08 mol) of end product, corresponding to a yield of 601.

Example 2 Preparation of 4-[(2',5'-diamino-6'-chloropyrimidin-4'-yl)amino]cyclopent-2-enylmethanol in the presence of diisopropylethylamine.
(1S,4R)-4-aminocyclopent-2-enylmethanol hydrochloride (0.14 mol, 23.18 g), butanol (1.26 mol, 93.39 g, 115.3 ml), 2,5-diamino-4,6-dichloropyrimidine (0.14 mol, 25.67 g) and diisopropylethylamine (0.29 mol, 37.09 g, 49.99 ml) were added to a dry reactor. This mixture was heated at reflux temperature (about 115 C) overnight. The rate of conversion was tested by TLC using 13/1 methylene chloride:methanol as mobile phase. The reaction mixture was cooled to room temperature. Water was then added, and the mixture was subsequently extracted twice with ethyl acetate.
The organic phase was washed twice with water, and then filtered through celiteTM. 2/3 of the organic phase were removed by distillation under reduced pressure, and hexane was then added dropwise. The suspension was cooled to below 10 C. After filtration, the product was dried under reduced pressure at 50 C.
This gave 21.47 g (0.08 mol) of end product, corresponding to a yield of 60%.

Claims (3)

THE EMBODIMENTS OF THE PRESENT INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. Process for preparing 4-[(2',5'-diamino-6'-halopyrimidin-4'-yl)amino]cyclopent-2-enylmethanols of the general formula in which X is a halogen atom, wherein a 2,5-diamino-4,6-dihalopyrimidine of the general formula in which X is defined as above, is reacted with a 4-aminocyclopent-2-enylmethanol of the formula or one of its salts, in the presence of a base selected from the group consisting of an alkali metal bicarbonate, an alkali earth metal bicarbonate, an alkali metal carbonate and an alkali earth metal carbonate, in a polar protic solvent to give the end product of the general formula I.
2. Process according to claim 1, wherein the polar protic solvent used is a C1-4-alcohol.
3. Process according to Claim 1 or 2, wherein the reaction is carried out at a temperature of from 20°C to the reflux temperature of the solvent in question.
CA002348374A 1998-10-30 1999-10-29 Method for producing 4- [(2',5'- diamino-6'- halopyrimidine- 4'-yl)amino]- cyclopent- 2-enylmethanols Expired - Fee Related CA2348374C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP98120529.7 1998-10-30
EP98120529 1998-10-30
US14610599P 1999-07-29 1999-07-29
US60/146,105 1999-07-29
PCT/EP1999/008270 WO2000026193A1 (en) 1998-10-30 1999-10-29 Method for producing 4- [(2',5'- diamino-6'- halopyrimidine- 4'-yl)amino]- cyclopent- 2-enylmethanols

Publications (2)

Publication Number Publication Date
CA2348374A1 CA2348374A1 (en) 2000-05-11
CA2348374C true CA2348374C (en) 2009-04-07

Family

ID=56289961

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002348374A Expired - Fee Related CA2348374C (en) 1998-10-30 1999-10-29 Method for producing 4- [(2',5'- diamino-6'- halopyrimidine- 4'-yl)amino]- cyclopent- 2-enylmethanols

Country Status (14)

Country Link
EP (1) EP1124805B1 (en)
JP (1) JP4457496B2 (en)
CN (1) CN1115338C (en)
AT (1) ATE240945T1 (en)
AU (1) AU1158000A (en)
CA (1) CA2348374C (en)
CZ (1) CZ300155B6 (en)
DK (1) DK1124805T3 (en)
ES (1) ES2200594T3 (en)
HU (1) HU227559B1 (en)
IL (1) IL142760A (en)
PL (1) PL198180B1 (en)
SK (1) SK285271B6 (en)
WO (1) WO2000026193A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100606625B1 (en) 1998-10-30 2006-07-28 론자 아게 Method for producing 4-[2',5'-diamino-6'-halopyrimidine-4'-ylamino]-cyclopent-2-enylmethanols
AU2008204380B2 (en) 2007-01-10 2013-08-15 Msd Italia S.R.L. Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors
CN101932572A (en) 2008-01-08 2010-12-29 默沙东有限公司 2-{4-[(3S)-and piperidines-3-yl] phenyl }-pharmacologically acceptable salts of 2H-indazole-7-carboxylic acid amides
CN103626745B (en) * 2013-12-04 2016-02-24 青岛黄海制药有限责任公司 A kind of preparation method of ticagrelor midbody

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE505213C2 (en) * 1988-01-20 1997-07-14 Univ Minnesota Dideoxycarbocyclic nucleoside analogues, pharmaceutical preparations thereof and intermediates
GB8916698D0 (en) * 1989-07-21 1989-09-06 Beecham Group Plc Novel process
MY104575A (en) * 1989-12-22 1994-04-30 The Wellcome Foundation Ltd Therapeutic nucleosides.
CA2145928C (en) * 1994-04-27 2007-10-09 Gerhard Stucky N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide, and a process for its preparation
KR100577891B1 (en) * 1996-05-30 2006-05-10 론자 아게 Enzymes having n-acylamino-alcohol hydrolase activity

Also Published As

Publication number Publication date
CZ20011486A3 (en) 2001-10-17
PL198180B1 (en) 2008-06-30
DK1124805T3 (en) 2003-09-15
EP1124805A1 (en) 2001-08-22
WO2000026193A1 (en) 2000-05-11
CZ300155B6 (en) 2009-02-25
JP2003500333A (en) 2003-01-07
SK5692001A3 (en) 2001-12-03
SK285271B6 (en) 2006-10-05
PL347503A1 (en) 2002-04-08
AU1158000A (en) 2000-05-22
CN1325386A (en) 2001-12-05
ATE240945T1 (en) 2003-06-15
IL142760A0 (en) 2002-03-10
EP1124805B1 (en) 2003-05-21
CN1115338C (en) 2003-07-23
HUP0104045A2 (en) 2002-05-29
IL142760A (en) 2005-12-18
ES2200594T3 (en) 2004-03-01
HU227559B1 (en) 2011-08-29
JP4457496B2 (en) 2010-04-28
HUP0104045A3 (en) 2002-07-29
CA2348374A1 (en) 2000-05-11

Similar Documents

Publication Publication Date Title
SK280940B6 (en) Process for the synthesis of (4r-cis)-1,1-dimethylethyl-6- -cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate, and intermediates of this process
KR20230137282A (en) Intermediates useful for the synthesis of a selective inhibitor against protein kinase and processes for preparing the same
CA2348374C (en) Method for producing 4- [(2',5'- diamino-6'- halopyrimidine- 4'-yl)amino]- cyclopent- 2-enylmethanols
US5552557A (en) Process for preparing 2-cyanoimidazole compounds by reaction of an amino ketone compound
CA2383751C (en) Intermediates for the production of quinolone carboxylic acid derivatives
EP0990647B1 (en) Process for producing quinolone derivatives
KR100481570B1 (en) Intermediates for the preparation of 2-imidazoline-5-ones
CN112661668B (en) N-substituted amide compound and preparation method thereof
US6433170B1 (en) Method for producing 4-[2',5'-diamino-6'-halopyrimidine-4'-yl)amino]- cyclopent-2-enylmethanols
US8030486B2 (en) Succinic acid diester derivative, process for production thereof, and use of the derivative in the production of pharmaceutical preparation
AU776300B2 (en) Synthesis of 3-amino-3-aryl propanoates
JPH01311046A (en) Production of oxalic acid derivative
US20060035913A1 (en) Method for the production of 2-amino-4-chloro-6-alkoxypyrimidines
MXPA01004227A (en) Method for producing 4- [(2',5'- diamino- 6'- halopyrimidine- 4'-yl)amino]- cyclopent- 2- enylmethanols
JP2002155059A (en) Method for producing 4-amino-5-cyanoimidazole derivative and intermediate thereof
CN115806519A (en) Method for splitting intermediate of brivaracetam and application of intermediate
CA3100685A1 (en) Novel processes for preparing a diaminopyrimidine derivative or acid addition salt thereof
NZ237143A (en) Process for preparing uracil derivatives
JPS63165354A (en) Production of asymmetric cyanhydrin
SK169397A3 (en) Aminophenyl ketone derivatives and preparation method thereof
KR20030068853A (en) Method for preparing of cinnamic acid derivatives
MXPA01001853A (en) Process for preparing regiospecific substituted pyrazine isomers
IE870687L (en) Pyridine derivatives
JP2001278865A (en) Method for producing 4-aminoquinolines
NO164975B (en) Intermediates.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20141029